ERIN WEISS: Open Payments
NPI 1659343085 · JEFFERSON CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$361 in 27 payments from 11 companies in 2025. Trend: 2023 $1,466 · 2024 $461 · 2025 $361
Food & beverage: $361
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $165 |
| Astellas Pharma US Inc | 1 | $28 |
| Medtronic, Inc. | 1 | $26 |
| CeQur Corporation | 1 | $21 |
| Corcept Therapeutics | 1 | $21 |
| TOLMAR, INC. | 1 | $18 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Amgen Inc. | 1 | $17 |
| PFIZER INC. | 1 | $15 |
Products named: Ozempic, Wegovy, Veozah, KYPHON EXPRESS II KYPHOPAK TRAY, Rybelsus, CeQur Simplicity, Korlym, JATENZO.
Industry payments across MO — which companies pay providers there.
